Platinum™ Taq DNA Polymerase, High Fidelity
Platinum&trade; <i>Taq</i> DNA Polymerase, High Fidelity
Citations & References (4)
Invitrogen™

Platinum™ Taq DNA Polymerase, High Fidelity

Platinum Taq DNA Polymerase, High Fidelity, is ideal for amplification of DNA fragments when high yields and robust amplification are required.
Have Questions?
Change viewbuttonViewtableView
Catalog NumberNo. of Reactions
11304029500 Reactions
11304011100 Reactions
113041025000 Reactions
Catalog number 11304029
Price (MXN)
-
No. of Reactions:
500 Reactions
Request bulk or custom format
Platinum Taq DNA Polymerase, High Fidelity, is ideal for amplification of DNA fragments when high yields and robust amplification are required. High fidelity is provided by a mixture of Platinum Taq DNA Polymerase and the proofreading enzyme. PCR specificity is improved with built-in Platinum hot-start technology.

Features of Platinum Taq DNA Polymerase, High Fidelity

  • Greater than six times higher fidelity than Taq DNA polymerase
  • Amplification of fragments up to 15 kb
  • Convenient room temperature reaction assembly
  • Increased specificity, and yield

Applications

  • Amplification of complex DNA templates
  • Amplification of viral and plasmid templates
  • RT-PCR
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Fidelity (vs. Taq)6X
Hot StartBuilt-In Hot Start
No. of Reactions500 Reactions
OverhangMixed
PolymerasePlatinum Taq DNA Polymerase High Fidelity
Product TypeDNA Polymerase High Fidelity
Quantity500 rxns
Reaction FormatSeparate Components
Shipping ConditionDry Ice
Size (Final Product)20 kb or less
Detection MethodPrimer-probe
For Use With (Application)Hot-start PCR, High-fidelity PCR
GC-Rich PCR PerformanceLow
Reaction SpeedStandard
Unit SizeEach
Contents & Storage
• Platinum Taq DNA Polymerase High Fidelity (1 x 100 μL at 5 U/μL)
• 10X High Fidelity Buffer (1 x 2.25 mL)
• 50 mM MgSO4 (1 x 1 mL)

Store at -10°C to -30°C.

Frequently asked questions (FAQs)

My oligonucleotide does not appear to be the right length when I checked by gel electrophoresis. Why is this?

Oligos should be run on a polyacrylamide gel containing 7 M urea and loaded with a 50% formamide solution to avoid compressions and secondary structures. Oligos of the same length and different compositions can electrophorese differently. dC's migrate fastest, followed by dA's, dT's, and then dG's. Oligos containing N's tend to run as a blurry band and generally have a problem with secondary structure.

The primers I am using worked for PCR initially, but over time, have stopped working. What happened?

Primers should be aliquoted for single use before PCR set-up. Heat just the aliquoted primers to 94 degrees for 1 min. Quick chill the primer on ice before adding to the PCR reaction. Some primers may anneal to themselves or curl up on themselves.

I don't see a pellet in my oligo tube order. Should I ask for a replacement?

The drying method dries the primer in a thin layer along the sidewalls of the tube instead of the bottom, therefore a pellet is not always visible and should still be ready to use.

There is a ball-shaped pellet at the bottom of my oligo tube. What is this and can I still use my oligo?

If the oligo was overheated, it will appear as a “ball”-shaped pellet attached to the bottom of the tube. This should not affect the quality of the oligo, and the oligo should be readily soluble in water.

There is a green color in my lyophilized oligo. Can I still use it?

If an oligo appears green in color, this is most likely due to ink falling into the tube. The oligo should still be fully functional. The color can be removed by doing an ethanol precipitation.

View all Platinum™ Taq DNA Polymerase, High Fidelity FAQs

Citations & References (4)

Citations & References
Abstract
Relation between kidney function, proteinuria, and adverse outcomes.
Authors:Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M
Journal:JAMA
PubMed ID:20124537
'The current staging system for chronic kidney disease is based primarily on estimated glomerular filtration rate (eGFR) with lower eGFR associated with higher risk of adverse outcomes. Although proteinuria is also associated with adverse outcomes, it is not used to refine risk estimates of adverse events in this current system.' ... More
Factor B and the mitochondrial ATP synthase complex.
Authors: Belogrudov Grigory I; Hatefi Youssef;
Journal:J Biol Chem
PubMed ID:11744738
Factor B is a subunit of the mammalian ATP synthase complex, whose existence has been controversial. This paper describes the molecular and functional properties of a recombinant human factor B, which when added to bovine submitochondrial particles depleted of their factor B restores the energy coupling activity of the ATP ... More
Human protein factory for converting the transcriptome into an in vitro-expressed proteome,.
Authors:Goshima N, Kawamura Y, Fukumoto A, Miura A, Honma R, Satoh R, Wakamatsu A, Yamamoto J, Kimura K, Nishikawa T, Andoh T, Iida Y, Ishikawa K, Ito E, Kagawa N, Kaminaga C, Kanehori K, Kawakami B, Kenmochi K, Kimura R, Kobayashi M, Kuroita T, Kuwayama H, Maruyama Y, Matsuo K, Minami K, Mitsubori M, Mori M, Morishita R, Murase A, Nishikawa A, Nishikawa S, Okamoto T, Sakagami N, Sakamoto Y, Sasaki Y, Seki T, Sono S, Sugiyama A, Sumiya T, Takayama T, Takayama Y, Takeda H, Togashi T, Yahata K, Yamada H,
Journal:Nat Methods
PubMed ID:19054851
Appropriate resources and expression technology necessary for human proteomics on a whole-proteome scale are being developed. We prepared a foundation for simple and efficient production of human proteins using the versatile Gateway vector system. We generated 33,275 human Gateway entry clones for protein synthesis, developed mRNA expression protocols for them ... More
Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencing.
Authors:Hu H, Wrogemann K, Kalscheuer V, Tzschach A, Richard H, Haas SA, Menzel C, Bienek M, Froyen G, Raynaud M, Van Bokhoven H, Chelly J, Ropers H, Chen W
Journal:Hugo J
PubMed ID:21836662
Massive parallel sequencing has revolutionized the search for pathogenic variants in the human genome, but for routine diagnosis, re-sequencing of the complete human genome in a large cohort of patients is still far too expensive. Recently, novel genome partitioning methods have been developed that allow to target re-sequencing to specific ... More